PMD34 A Novel Ibs Diagnostic Blood Panel Can Enhance A Positive Diagnostic Strategy Versus A Strategy Of Exclusion For Patients With Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D): Cost Implications For Denmark

C Purdy; P M Bytzer; M.M. Pimentel; R Magar

doi:10.1016/j.jval.2015.09.635

PMD34 A Novel Ibs Diagnostic Blood Panel Can Enhance A Positive Diagnostic Strategy Versus A Strategy Of Exclusion For Patients With Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D): Cost Implications For Denmark

C Purdy, P M Bytzer, M.M. Pimentel, R Magar

Institut for Klinisk Medicin

Originalsprog	Engelsk
Tidsskrift	Value in Health
Vol/bind	18
Udgave nummer	7
Sider (fra-til)	A350
ISSN	1098-3015
DOI	https://doi.org/10.1016/j.jval.2015.09.635
Status	Udgivet - nov. 2015

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1016/j.jval.2015.09.635

http://www.valueinhealthjournal.com/article/S1098301515027114/pdf

Citationsformater

PMD34 A Novel Ibs Diagnostic Blood Panel Can Enhance A Positive Diagnostic Strategy Versus A Strategy Of Exclusion For Patients With Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D) : Cost Implications For Denmark. / Purdy, C; Bytzer, P M; Pimentel, M.M. et al.

I: Value in Health, Bind 18, Nr. 7, 11.2015, s. A350.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

@article{840987eb3dad4f5f8b9d52ef22d35f03,

title = "PMD34 A Novel Ibs Diagnostic Blood Panel Can Enhance A Positive Diagnostic Strategy Versus A Strategy Of Exclusion For Patients With Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D): Cost Implications For Denmark",

keywords = "Journal Article",

author = "C Purdy and Bytzer, {P M} and M.M. Pimentel and R Magar",

year = "2015",

month = nov,

doi = "10.1016/j.jval.2015.09.635",

language = "English",

volume = "18",

pages = "A350",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier",

number = "7",

}

TY - ABST

T1 - PMD34 A Novel Ibs Diagnostic Blood Panel Can Enhance A Positive Diagnostic Strategy Versus A Strategy Of Exclusion For Patients With Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D)

T2 - Cost Implications For Denmark

AU - Purdy, C

AU - Bytzer, P M

AU - Pimentel, M.M.

AU - Magar, R

PY - 2015/11

Y1 - 2015/11

KW - Journal Article

U2 - 10.1016/j.jval.2015.09.635

DO - 10.1016/j.jval.2015.09.635

M3 - Conference abstract in journal

C2 - 26531981

SN - 1098-3015

VL - 18

SP - A350

JO - Value in Health

JF - Value in Health

IS - 7

ER -